Chembio Diagnostics, Inc.
CEMIDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001092662
Chembio Diagnostics, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on May 2, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $1.36M in total; no superinvestor held it.
Holders of 5% or more of CEMI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Chembio Diagnostics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Chembio Diagnostics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Chembio Diagnostics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 4, 2023 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| May 1, 2023 | Biosynex SA | 13DOld format | – | New | – | SEC |
| Apr 24, 2023 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Apr 7, 2023 | Perceptive Advisors LLC | 13DOld format | – | New | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jul 12, 20218:29 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Lytton Laurence W | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Nantahala Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Jan 29, 2021 | Royce & Associates LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Chembio Diagnostics, Inc. shares.
No Form 144 notices for Chembio Diagnostics, Inc. are on file.